Notable Gainers: TOP Ships (NASDAQ:TOPS), Sarepta Therapeutics Inc (NASDAQ:SRPT), ANI Pharmaceuticals (NASDAQ:ANIP), Tarena International (NASDAQ:TEDU)

TOP Ships Inc. (NASDAQ:TOPS), an international maritime shipping company that provides transportation services for petroleum products and dry bulk commodities, announced that it has entered into three Stock Purchase Agreements with an affiliate of the AMCI Poseidon investment fund by which the Company has agreed to sell the six shipowning subsidiaries which own the Company’s six vessels, for an aggregate cash consideration of approximately $173 … Continue reading Notable Gainers: TOP Ships (NASDAQ:TOPS), Sarepta Therapeutics Inc (NASDAQ:SRPT), ANI Pharmaceuticals (NASDAQ:ANIP), Tarena International (NASDAQ:TEDU)

Unusual Volume Buzzers: Cbeyond (NASDAQ:CBEY), Advanced Micro Devices (NYSE:AMD), Sarepta Therapeutics Inc (NASDAQ:SRPT), AstraZeneca (NYSE:AZN)

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Cbeyond, Inc. (NASDAQ:CBEY) and other violations of state law by the board of directors of Cbeyond Inc. (NASDAQ:CBEY) relating to the proposed buyout of the Company by Birch Communications, Inc. (“Birch”). Cbeyond, Inc. (NASDAQ:CBEY) stock performance was 38.56% in last … Continue reading Unusual Volume Buzzers: Cbeyond (NASDAQ:CBEY), Advanced Micro Devices (NYSE:AMD), Sarepta Therapeutics Inc (NASDAQ:SRPT), AstraZeneca (NYSE:AZN)

Shares of Regulus Therapeutics Inc (NASDAQ:RGLS) were the target of a significant decrease in short interest in January. As of March 14th, there was short interest totaling 1,460,571 shares, a decrease of 20.3% from the February 28th total of 1,832,140 shares, Analyst Ratings Newsreports. Regulus Therapeutics Inc (NASDAQ:RGLS) stock performance was 5.09% in last session and finished the day at $7.64. Traded volume was 161,836.00million … Continue reading Biotech Bullish Stocks: Regulus Therapeutics Inc (NASDAQ:RGLS), Insys Therapeutics (NASDAQ:INSY), Repligen Corporation (NASDAQ:RGEN), Sarepta Therapeutics (NASDAQ:SRPT)

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego. Presentations will include a clinical pilot study evaluating the feasibility of using ferumoxytol* as an MRI imaging agent prior to MM-398 investigational treatment. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 6.15% in … Continue reading Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Drugmaker Merck said on Oct 01, that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 billion. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is 0.86%. On last trading day company shares ended up $59.90. … Continue reading Best Stocks : Merck & Co. Inc. (NYSE:MRK), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), American Campus Communities, Inc. (NYSE:ACC), Kosmos Energy Ltd. (NYSE:KOS), NRZ

Chris Garabedian, President and CEO Sarepta Therapeutics, Inc. (NASDAQ:SRPT), announced that the Phase IIb clinical study on its first product, eteplirsen, will have its results submitted to the FDA by the end of the year, with a launch slated for mid next-year if approved. He was speaking at the Canaccord Genuity 34th Annual Growth Conference at the Intercontinental Hotel in Boston, Massachusetts. Sarepta Therapeutics, Inc. … Continue reading Stocks in Focus : Sarepta Therapeutics (NASDAQ:SRPT), Google Inc (NASDAQ:GOOGL), B&G Foods Inc. (NYSE:BGS), Repros Therapeutics Inc. (NASDAQ:RPRX), Tejon Ranch (NYSE:TRC)